Clinical Trial: A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229742) titled 'A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis' on Nov. 13.

Brief Summary: The study is a Phase II clinical trial to evaluate the efficacy and safety of SHR-2173 in patients with lupus nephritis (LN). It adopts a randomized, double-blind, placebo-controlled, multicenter trial design.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Active Lupus Nephritis

Intervention: DRUG: SHR-2173 Injection

SHR-2173 injection.

DRUG: SHR-2173 Injection Blank Preparation

SHR-2173 injection blank preparation.

Recruitment Status: NOT_YET_RE...